Propane-1,2,3-triyl (13Z,13'Z,13''Z)-tris(docos-13-enoate)

Catalog No. :
ACYNSX137
CAS No. :
2752-99-0
Molecular Formula :
C69H128O6
Molecular Weight :
1053.78

IUPAC Name:propane-1,2,3-triyl (13Z,13'Z,13''Z)-tris(docos-13-enoate)

Propane-1,2,3-triyl (13Z,13'Z,13''Z)-tris(docos-13-enoate) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg97%$69.00Login to see priceInquiryInquiry
25mg97%$120.00Login to see priceInquiryInquiry
50mg97%$178.00Login to see priceInquiryInquiry
100mg97%$267.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePropane-1,2,3-triyl (13Z,13'Z,13''Z)-tris(docos-13-enoate)
IUPAC Namepropane-1,2,3-triyl (13Z,13'Z,13''Z)-tris(docos-13-enoate)
MDL No.MFCD00056321
Molecular FormulaC69H128O6
Molecular Weight1053.78
SMILESCCCCCCCC/C=C\CCCCCCCCCCCC(OCC(COC(CCCCCCCCCCC/C=C\CCCCCCCC)=O)OC(CCCCCCCCCCC/C=C\CCCCCCCC)=O)=O
InChI KeyXDSPGKDYYRNYJI-IUPFWZBJSA-N
SynonymF82435 | GLYCERYL TRIERUCATE [MART.] | AKOS000119841 | Glycerol Tri-13-docosenoate | (Z)-13-DOCOSENOIC ACID TRIGLYCERIDE | 13-Docosenoic acid, 1,2,3-propanetriyl ester | Glyceryl trierucate | Propane-1,2,3-triyl tris((Z)-docos-13-enoate) | CS-0100518 | N-
CAS No.2752-99-0
PubChem CID5463075

Synthetic Route by SureRoute

1. ACYNSX137 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFVZL907 route compound structure diagram
    ACFVZL907112-86-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYNSX137 route product structure diagram
    ACYNSX1372752-99-0
Inquiry

2. ACYNSX137 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYNSX137 route product structure diagram
    ACYNSX1372752-99-0
Inquiry

Comments (0)